Form 4: Semler Scientific Director Exercises Stock Options, Increases Holdings

Director Eric Semler exercised stock options to acquire 7,875 shares of Semler Scientific, Inc. common stock at a price of $23.32 per share.

Summary

• Eric Semler, a director at Semler Scientific, Inc., exercised stock options on December 16, 2024.
• This transaction involved the acquisition of 7,875 shares of common stock at a price of $23.32 per share.
• Following the transaction, Mr. Semler directly owns 629,596 shares of common stock.
• He also has indirect ownership of 77,771 shares through TCS Capital Advisors, LLC.
• The stock options exercised were part of a grant that vests monthly, with full vesting by April 24, 2026.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction by a company director, which is generally viewed as neutral to slightly positive. The exercise of options suggests confidence in the company's future.

Positives

• The exercise of stock options by a director can be seen as a positive sign of confidence in the company's future prospects.
• The director increased their direct holdings in the company.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders who trade company stock. It provides transparency into the transactions of company directors and officers.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the United States, ensuring transparency of insider transactions.
• The exercise of stock options by directors is a common form of compensation and is frequently seen across the industry.
• The vesting schedule of the options is also typical, with monthly vesting over a period of time.

Stakeholder Impact

• The transaction increases the director's stake in the company, aligning his interests with those of other shareholders.
• The exercise of options does not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

stock options, insider trading, beneficial ownership, Semler Scientific, SMLR, equity securities, director, Eric Semler